These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 1745145

  • 1. [Determination of the immune potency of lymphocyte-promoting factor (LPF) and filamentous hemagglutinin (FHA) molecules by intranasal challenge in mice].
    Ozcengiz E, Günalp A.
    Mikrobiyol Bul; 1991 Apr; 25(2):131-7. PubMed ID: 1745145
    [Abstract] [Full Text] [Related]

  • 2. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H, Sato Y.
    Dev Biol Stand; 1985 Apr; 61():461-7. PubMed ID: 2872127
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
    Tiru M, Jäätmaa E, Gillenius P, Askelöf P.
    Dev Biol Stand; 1985 Apr; 61():469-75. PubMed ID: 2872128
    [Abstract] [Full Text] [Related]

  • 9. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.
    Sato Y, Izumiya K, Sato H, Cowell JL, Manclark CR.
    Infect Immun; 1981 Mar; 31(3):1223-31. PubMed ID: 6262248
    [Abstract] [Full Text] [Related]

  • 10. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.
    Kimura A, Mountzouros KT, Relman DA, Falkow S, Cowell JL.
    Infect Immun; 1990 Jan; 58(1):7-16. PubMed ID: 2294058
    [Abstract] [Full Text] [Related]

  • 11. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
    Cahill ES, O'Hagan DT, Illum L, Barnard A, Mills KH, Redhead K.
    Vaccine; 1995 Apr; 13(5):455-62. PubMed ID: 7639014
    [Abstract] [Full Text] [Related]

  • 12. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.
    Mielcarek N, Riveau G, Remoué F, Antoine R, Capron A, Locht C.
    Nat Biotechnol; 1998 May; 16(5):454-7. PubMed ID: 9592394
    [Abstract] [Full Text] [Related]

  • 13. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES, O'Hagan DT, Illum L, Redhead K.
    FEMS Microbiol Lett; 1993 Mar 01; 107(2-3):211-6. PubMed ID: 8472903
    [Abstract] [Full Text] [Related]

  • 14. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP, Pohl-Koppe A.
    Eur J Med Res; 1998 Nov 17; 3(11):523-6. PubMed ID: 9810032
    [Abstract] [Full Text] [Related]

  • 15. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis.
    McGuirk P, Mills KH.
    Eur J Immunol; 2000 Feb 17; 30(2):415-22. PubMed ID: 10671196
    [Abstract] [Full Text] [Related]

  • 16. Antibodies produced against a fragment of filamentous haemagglutinin (FHA) of Bordetella pertussis are able to inhibit hemagglutination induced by the whole adhesin.
    Colombi D, Horton DS, Oliveira ML, Sakauchi MA, Ho PL.
    FEMS Microbiol Lett; 2004 Nov 01; 240(1):41-7. PubMed ID: 15500977
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.
    Clin Infect Dis; 1999 Mar 01; 28(3):552-9. PubMed ID: 10194077
    [Abstract] [Full Text] [Related]

  • 20. Biologic and protective properties of the 69-kDa outer membrane protein of Bordetella pertussis: a novel formulation for an acellular pertussis vaccine.
    Novotny P, Chubb AP, Cownley K, Charles IG.
    J Infect Dis; 1991 Jul 01; 164(1):114-22. PubMed ID: 2056199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.